Commentary: Novel Use of Offset Analgesia to Assess Adolescents and Adults with Treatment Resistant Endometriosis-Associated Pain

Claire E Lunde, Szabo E, Edina Szabo, Edina Szabó, Scott A Holmes, Holmes SA, Borsook D, David Borsook, Christine B. Sieberg
Journal of pain research · 2020 · vol. Volume 13 , pp. 2775–2782 · doi:10.2147/jpr.s276135 · PMID:33204144 · PMC7660453 · W3097271996
article OA: gold CC0 ⤵ 3 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-18 ⓘ

This commentary proposes using offset analgesia to investigate the neural mechanisms maintaining endometriosis-associated pain, identify individuals at risk for chronic pain, and inform the development of centrally mediated treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND AND OBJECTIVE: Endometriosis, affecting approximately 176 million adults and adolescents worldwide, is a debilitating condition in which uterine tissue grows outside the uterus. The condition costs the US economy approximately $78 billion annually in pain-related disability. By understanding the neural underpinnings of endometriosis-associated pain (EAP) and risk factors for chronification, translational research methods could lessen diagnostic delays and maximize successful pain remediation. This can be accomplished by the novel use of a known method, offset analgesia (OA), to better elucidate the neural mechanisms that may contribute to and maintain EAP. This commentary will provide justification and rationale for the use of OA in the study of EAP. CONCLUSION: Utilizing an OA paradigm in patients with endometriosis, especially adolescents, may (1) provide insight into neural mechanisms contributing to pain maintenance, which could capture those at-risk for the transition to chronic pelvic pain, (2) provide a metric for the development of future centrally mediated treatment options for this population, and (3) elucidate the brain changes that result in resistance to treatment and pain chronification.
Full text 19,858 characters · extracted from pmc-nxml · 5 sections · click to expand

Offset

Although OA responses have been found to be attenuated in patients with various chronic pain conditions, it is unknown in EAP. Only two studies have used CPM on patients with EAP 41 and patients with dysmenorrhea 42 (common symptom and predictor of endometriosis) which reported inconsistent results, calling for further investigation within this population. Furthermore, less efficient CPM was reported in comparable disorders such as irritable bowel syndrome 43 or CPP syndrome, 44 but not in premenstrual dysphoric disorder. 45 It should be also noted that the role of female-specific reproductive hormones on sensation and perception is not fully understood, although some studies have found that the menstrual cycle influences pain sensations elicited by noxious stimuli. 46–49 In line with this, OA has been found to be somatotopically organized in episodic migraine, a cyclic disease where pain perception changes according to the migraine phase. 39 Specifically, OA responses were measured at the forehead and forearm during the headache-free period, and the impaired pain inhibition was restricted to the affected area (the head). Based on these results, measuring OA on the lower abdomen (besides the forearm, which is the most commonly used examination site) should be considered in patients with EAP. With ongoing pain (intermittent or constant), alterations in the sensitivity/responsivity of neural networks encompass those beyond the classic sensory pathways (eg, spinothalamic tract) and involve anxiety, cognition, memory, and the normal function of the brain’s pain inhibitory (descending modulation) systems are thought to take place. 50 Through these changes in neural networks, one measurable process is a change in descending pain inhibition, which can be evaluated using the described OA paradigm. Given that EAP is a multi-faceted and complex problem, there is a desperate need for a new approach to understand the neural mechanisms in both adult and pediatric cases of endometriosis. This could be accomplished by using translational research methods, such as OA, to determine if the brain regions associated with pain evolution and maintenance have been altered, leading to increased pain sensitivity which in turn could lead to an earlier finding of a more effective treatment. Based on the aforementioned results, the diminished endogenous pain inhibition measured with OA would thus be a reflection of an altered brain system in which there is an increased sensitivity to pain and increased resistance to treatment in conditions such as CPP associated with endometriosis. A better understanding of the neural mechanisms occurring in the CNS and of the role of the brain’s inhibitory response system in the development, maintenance, and exacerbation of EAP would provide a necessary paradigm shift for the field of adolescent and adult female reproductive health. Specifically, assessing the OA response in this patient population would: (1) enhance our understanding of the structural and functional alterations in the CNS pain regulatory system due to CPP in patients with endometriosis; (2) provide a measurable change in the brain’s structure to follow such patients in the clinic; (3) potentially provide a measurable change in the brain for those who will develop EAP; and (4) define an initial paradigm that may enhance our capability for developing individually tailored patient-oriented interventions.

Paradigm

Evaluating OA responses could be beneficial in a clinical setting because it would give further information about the patient responses to different interventions. There have only been a few studies assessing the role of pharmacological interventions on the OA response and indicate that while the magnitude of OA was not affected by different analgesics, the reported clinical pain intensity decreased after treatment, 17 , 18 , 20 indicating that pain relief may not necessarily be associated with the normalization of the central pain inhibiting system. Other centrally targeted therapies, such as Cognitive Behavioral Therapy, have largely been unexplored as they relate to the OA response. Patients with endometriosis and CPP appear to be a heterogeneous group with different levels of peripheral and central sensitization. Thus, some patients are likely to react better to therapies involving pharmacologic and cognitive-behavioral approaches that focus on the central aspect of pain than to repeated surgeries aimed at treating endometriosis. The OA paradigm might provide a useful tool to predict or confirm treatment responders vs non-responders and to reveal the extent to which different treatments can contribute to reversing the central changes.

Conclusion

By understanding the neural underpinnings of endometriosis-associated pain and risk factors for chronification, translational research methods, such as OA, could lessen diagnostic delays and maximize successful pain remediation. As OA has been administered at the volar side of the arm and the same time intervals (5 s, 5 s, 20 s) for many studies, this can be the recommended procedure for future studies of adolescents and women with treatment resistant endometriosis-associated EAP. Additionally, using the lower abdomen as an examination site should be considered. There is great need for estimating OA in patients with endometriosis, especially adolescents, as the way forward because it can: (1) provide insight into neural mechanisms contributing to pain maintenance, which could capture those at-risk for the transition to CPP, (2) provide a metric for the development of future centrally mediated treatment options for this population, and (3) elucidate the brain changes that result in resistance to treatment and pain chronification. This novel use of an existing tool is of paramount importance due to the reduced quality of life in young patients and for the known grim condition outcomes in adulthood. To date, no previous studies have explored OA in adult or pediatric patients with EAP and given that most patients report symptoms of EAP during adolescence, this would be a critical time to investigate pain modulation with the goal of decreasing pain in women with endometriosis. More research in understanding the underlying neural mechanisms and centralized effects of pain within adolescents and adults with endometriosis is of great importance and the proposed utilization of OA in this population will hopefully move the field of reproductive health forward.

Peripheral

One main reason for the lack of effective treatments is a poor understanding of the neural mechanisms contributing to the maintenance and exacerbation of pain in this population. Historically, the pain associated with endometriosis has been conceptualized and treated peripherally (eg, surgical excision of the lesion, oral contraceptives, NSAIDs, etc.) resulting from inflammatory nociceptive molecules or damaged nerves, leaving the role of the CNS largely ignored. 6 Studies exploring changes in the CNS have found increased sensitivity to pain within and outside of the areas of the pelvis among endometriosis patients, as well as decreased gray matter volume (GMV) and increased functional connectivity in brain regions involved in pain processing such as the medial prefrontal cortex, anterior insula, cingulate gyrus, thalamus and putamen. 7 , 8 In line with this, endometriosis patients without CPP did not show hyperalgesia and reduced GMV, but they exhibited increased GMV in the periaqueductal gray (PAG) which is an important structure in the endogenous pain modulation system. 8 Such findings support the notion that the alterations in the central processing of pain likely contribute to CPP in endometriosis.

Endometriosis

Endometriosis, a debilitating condition in which uterine tissue grows outside the uterus, affects approximately 176 million adults and adolescents worldwide 1 and costs the US economy approximately $78 billion annually in pain-related disability. 2 It has a deleterious impact on physical and emotional functioning, as well as quality of life, and is the leading cause of chronic pelvic pain (CPP). 3 Following laparoscopic surgery, to both confirm the diagnosis and remove the ectopic tissue, patients are commonly managed with a hormonal regimen during the childbearing years. Despite these treatments, approximately 30% of women report no improvement in pain after surgery and many other patients report frequently recurring endometriosis-associated pain (EAP) without evidence of recurrent disease. 4 With this high prevalence of pain and disease burden, there is a lack of effective treatments for this subset of treatment non-responders who continue to experience EAP. 5 Endometriosis in adolescents is an even more challenging problem as it may present with a number of clinical and pathological differences that are not observed in adult women. Nevertheless, given the chronicity of the disease, the challenge is to avoid a delay in diagnosis, understand the disease, and direct effective therapies at an early age. 6 Small pilot studies 7 , 8 in adult women have shown the maintenance and chronicity of EAP to be associated with structural and functional alterations in regions related to pain modulation suggesting that EAP is not explained by endometriosis alone, but alternatively may be explained by dysfunction in the Central Nervous System (CNS) either as a defective pain modulatory system or an increase in neuronal responsivity in central sensory and emotional pain pathways. Recent animal models have shown that the type of nerve that innervates the endometriosis lesion, as well as the location of the lesion, impact the CNS differently and thus dictate how the pain is modulated, such as peripherally, centrally, and by other central dynamic processes. 9 As the onset of this condition may begin before menarche 10 , 11 and adult women report their symptoms beginning during adolescence, 12 addressing early pre-symptomatic markers of pain chronification in the pediatric brain may change the prognosis by increasing the quality of life and protecting the health and reproductive system of adolescents with endometriosis. This can be accomplished by the novel use of a known method to better elucidate the neural mechanisms that may contribute to and maintain EAP – offset analgesia (OA). OA is increasingly used to measure endogenous pain inhibition, which is considered one of the central mechanisms facilitating (or preventing) pain and contributing to pain chronification.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (50)

Cited by (3)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:36.268089+00:00
License: CC0 · commercial use OK